Univest
Univest
  • Markets

Valiant Laboratories Ltd. Hits Lower Circuit on BSE, 28 October 2026

  • October 1, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Valiant Laboratories lower circuit today on BSE

Existing holders of Valiant Laboratories Ltd. (VALIANTLAB) and prospective buyers faced very different positions on 28 October 2026. The Valiant Laboratories lower circuit sits at Rs 121.75 on BSE, 1.97% under the previous close of Rs 124.2, and anyone wanting out met a band that left no room to sell lower.

Market cap is Rs 674.56 crore, and the stock was locked at the band for the third session in a row at the time of writing.

Table of Contents

Toggle
  • Key Takeaways
  • Key Market Data
  • Price Action and Trading Activity
  • Why Valiant Laboratories Ltd. Hit Lower Circuit
  • What the Valiant Laboratories Lower Circuit Means
  • Valiant Laboratories Ltd. Fundamentals and Valuation
  • Peer and Sector Context
  • Technical Snapshot
  • What Readers Should Know
  • Frequently Asked Questions
    • Why did Valiant Laboratories Ltd. hit lower circuit on 28 October 2026?
    • What was VALIANTLAB share price on 28 October 2026?
    • What was the lower circuit price for VALIANTLAB?
    • What is Valiant Laboratories Ltd.’s market cap and PE ratio?
    • Which exchange and data source were used?
    • Does hitting a lower circuit mean Valiant Laboratories Ltd. is a buy or a sell?
    • Can you buy or sell Valiant Laboratories Ltd. shares when the stock is at the lower circuit?
    • What happens the next trading session after a lower circuit?
    • What is the lower circuit limit set at for Indian stocks?

Key Takeaways

  • Valiant Laboratories Ltd. (VALIANTLAB) hit the lower circuit on BSE at Rs 121.75 on 28 October 2026.
  • The session move was -1.97% against a previous close of Rs 124.2.
  • Market capitalisation stood at Rs 674.56 crore with a PE ratio of 42.14.
  • No official company announcement or verified catalyst was confirmed at the time of writing.
  • A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric Value
Stock Valiant Laboratories Ltd.
Current Price / LTP Rs 121.75
Day Move -1.97%
Previous Close Rs 124.2
Day Open Rs 121.75
Day High Rs 121.75
Day Low Rs 121.75
Lower Circuit Price Rs 121.75
Lower Circuit Limit Rs 121.75
Market Cap Rs 674.56 crore
Selected Exchange BSE
PE Ratio 42.14

All figures above are as of 28 October 2026, sourced from Univest market data for the BSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Valiant Laboratories Ltd. opened at Rs 121.75 on BSE, under the previous close of Rs 124.2, and its high, low and last price for the day all matched that level. In practice the stock sat on the lower circuit price from the first trade.

The fall came to Rs 2.45, a move of -1.97%. With the open and both extremes identical there is no intraday range to describe, and each figure is taken from BSE so the set stays consistent.

Bands and reference closes can differ across exchanges, which is why BSE alone is used. The limit for the session stood at Rs 121.75.

Why Valiant Laboratories Ltd. Hit Lower Circuit

Selling pressure drove Valiant Laboratories Ltd. to its exchange-defined price band. No official company announcement or verified external catalyst had been confirmed at the time of writing, so price action and market sentiment remain the main basis for reading the move.

The article therefore does not pin the fall on earnings, a corporate action, sector news or market rumours. A confirmed disclosure, if one emerges, would get its own update.

The lower circuit level the stock reached in the session was Rs 121.75.

What the Valiant Laboratories Lower Circuit Means

A lower circuit is the lowest price a stock can trade at within a session, as set by the exchange price band. For Valiant Laboratories Ltd., that lowest permitted price was Rs 121.75 on 28 October 2026.

The band is there to slow sharp moves and keep trading in order, which makes it a market-structure feature and not a prediction about returns. Here the circuit records what happened in the session and the level at which the band was reached.

Valiant Laboratories Ltd. Fundamentals and Valuation

Market data adds context beyond the price move. The figures on file for Valiant Laboratories Ltd. read PE 42.14, PB 2.03, book value Rs 61.13 per share and EPS 2.95, set against a market cap of Rs 674.56 crore. These are descriptive figures and not a buy, sell or hold view.

The reported EPS and return on equity contradict each other in the underlying dataset, so no conclusion on profitability is drawn here until that is sorted out.

Trading at 2.03 times book, the stock carried a value above its reported book value per share. Such a gap over book can come from growth hopes or asset quality, or simply from sparse trading in a small counter.

For existing holders and new buyers alike, these ratios help keep the price event separate from the wider financial profile. A sharp one-day move draws attention, yet valuation and returns still need to be reviewed on their own.

Peer and Sector Context

Valiant Laboratories Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company Market Cap PE PB ROE
Advanced Enzyme Technologies Ltd. Rs 2905.78 crore 17.52 1.75 11.43%
Hikal Ltd. Rs 2494.37 crore – 2.09 -3.97%
Fredun Pharmaceuticals Ltd. Rs 2490.64 crore 56.84 8.17 16.09%
Dishman Carbogen Amcis Ltd. Rs 2314.9 crore 143.25 0.35 1.56%
Beta Drugs Ltd. Rs 2151.07 crore 41.43 4.91 18.78%

A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.

Several of these peers are far larger by market capitalisation than Valiant Laboratories Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Valiant Laboratories Ltd.’s PE ratio was 42.14, compared with an available peer PE average of 64.76, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Want to know more? Log in to Univest for more stock insights.

Technical Snapshot

The technical snapshot adds context: RSI was 92.93, the 50-day moving average was 125.02 and the 200-day moving average was 88.8.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

What is confirmed: Valiant Laboratories Ltd. was at the lower circuit on BSE at Rs 121.75 on 28 October 2026, a day move of -1.97%.

For existing holders, the practical difficulty is getting out, since sell orders stack at the band with few buyers and an exit at the quoted price may not be possible. For prospective buyers, the same one-sided book is the main fact to register. Nothing official had surfaced to explain the fall by the time of writing.

A lower circuit is a market update and not a conclusion. It shows heavy selling for now, and deeper work would have to cover business fundamentals, valuation, liquidity, risk and confirmed company disclosures.

Frequently Asked Questions

Why did Valiant Laboratories Ltd. hit lower circuit on 28 October 2026?

The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was VALIANTLAB share price on 28 October 2026?

The last traded price used in this article was Rs 121.75 on BSE. That price matched the lower circuit price captured for the event.

What was the lower circuit price for VALIANTLAB?

The lower circuit price was Rs 121.75. The stated exchange lower circuit limit was Rs 121.75. The event numbers in this article are aligned to BSE.

What is Valiant Laboratories Ltd.’s market cap and PE ratio?

Valiant Laboratories Ltd.’s market cap was Rs 674.56 crore. PE ratio was 42.14.

Which exchange and data source were used?

The selected exchange was BSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting a lower circuit mean Valiant Laboratories Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Valiant Laboratories Ltd. shares when the stock is at the lower circuit?

It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.

What happens the next trading session after a lower circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the lower circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Valiant Laboratories Ltd. the stated limit was Rs 121.75. For this session, Valiant Laboratories Ltd. moved -1.97%.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply